‘Right To Try’ Bill Focuses On Sidestepping FDA, But In Reality It’s Drugmakers That Are Usually Ones Saying ‘No’

The bill passed by the House last week “does somewhere between nothing and absolutely nothing to help you," said Dr. Arthur L. Caplan, a bioethicist at New York University. Patients are actually getting blocked by the drug companies themselves. Meanwhile, California's drug transparency law has kicked in, but it's still unclear if it will be met with success in controlling costs.

from Kaiser Health News https://ift.tt/2pGC5s9